This announcement is a separate document:
九强生物：华创证券有限责任公司关于北京九强生物技术股份有限公司重大资产购买暨关联交易之2021年持续督导意见暨持续督导总结报告
Jiuqiang Biotech: Huacheng Securities Co., Ltd.'s 2021 Continued Supervision Opinions and Continued Supervision Summary Report on Major Asset Purchases and Related Transactions of Beijing Jiuqiang Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated